Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance

The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with pre-symptomatic, symptomatic, and asymptomatic infections, the re-opening of societies and the control of virus spread will be facilitated by robust surveillance, for which virus testing will often be central. After infection, individuals undergo a period of incubation during which viral titers are usually too low to detect, followed by an exponential viral growth, leading to a peak viral load and infectiousness, and ending with declining viral levels and clearance. Given the pattern of viral load kinetics, we model surveillance effectiveness considering test sensitivities, frequency, and sample-to-answer reporting time. These results demonstrate that effective surveillance depends largely on frequency of testing and the speed of reporting, and is only marginally improved by high test sensitivity. We therefore conclude that surveillance should prioritize accessibility, frequency, and sample-to-answer time; analytical limits of detection should be secondary.

[1]  The natural history and transmission potential of asymptomatic SARS-CoV-2 infection. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Perelson,et al.  Influenza A virus infection kinetics: quantitative data and models , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[3]  J. Chan,et al.  Associations of Clinical Characteristics and Antiviral Drugs with Viral RNA Clearance in Patients with COVID-19 in Guangzhou, China , 2020 .

[4]  Sarah K. Helman,et al.  Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset , 2020, eLife.

[5]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[6]  Paramveer S. Dhillon,et al.  Interdependence and the cost of uncoordinated responses to COVID-19 , 2020, Proceedings of the National Academy of Sciences.

[7]  D. Raoult,et al.  Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  Joel Hellewell,et al.  Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.

[9]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[10]  M. M. van der Eerden,et al.  Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants , 2020, medRxiv.

[11]  Yang Liu,et al.  Secondary attack rate and superspreading events for SARS-CoV-2 , 2020, The Lancet.

[12]  Lukas P. M. Kremer,et al.  A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples , 2020, Science Translational Medicine.

[13]  M. Koopmans,et al.  SARS-CoV-2 is transmitted via contact and via the air between ferrets , 2020, bioRxiv.

[14]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[15]  Rochelle P. Walensky,et al.  Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States , 2020, JAMA network open.

[16]  E. Lavezzo,et al.  Suppression of COVID-19 outbreak in the municipality of Vo, Italy , 2020, medRxiv.

[17]  Shahin Jabbari,et al.  Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City , 2020, Proceedings of the National Academy of Sciences.

[18]  S. Bhatt,et al.  Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ , 2020, Nature.

[19]  Mark Jit,et al.  Projecting social contact matrices in 152 countries using contact surveys and demographic data , 2017, PLoS Comput. Biol..

[20]  Eric Song,et al.  Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs , 2020, medRxiv.

[21]  M. Lipsitch,et al.  Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study , 2020, The Lancet Infectious Diseases.

[22]  Eric J Topol,et al.  Prevalence of Asymptomatic SARS-CoV-2 Infection , 2020, Annals of Internal Medicine.

[23]  Klasse Pj,et al.  Molecular determinants of the ratio of inert to infectious virus particles. , 2015 .

[24]  P. Klasse,et al.  Molecular determinants of the ratio of inert to infectious virus particles. , 2015, Progress in molecular biology and translational science.

[25]  Jian-ming Wang,et al.  Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China , 2020, Science China Life Sciences.

[26]  J. Chan,et al.  Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study , 2020, medRxiv.

[27]  D. Larremore,et al.  Reductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York City , 2020, Nature Communications.

[28]  Jorge X. Velasco-Hernandez,et al.  In-host Modelling of COVID-19 Kinetics in Humans , 2020, medRxiv.

[29]  Sarah K. Helman,et al.  Quantifying antibody kinetics and RNA shedding during early-phase SARS-CoV-2 infection , 2020, medRxiv.

[30]  The Murine Polyomavirus MicroRNA Locus Is Required To Promote Viruria during the Acute Phase of Infection , 2018, Journal of Virology.

[31]  O. Tsang,et al.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.

[32]  R. Baric,et al.  DNA vaccine protection against SARS-CoV-2 in rhesus macaques , 2020, Science.

[33]  Yoon-Seok Chung,et al.  Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea , 2020, Journal of Korean medical science.

[34]  Anne Kimball,et al.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.

[35]  S. Bhatt,et al.  Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study , 2020, The Lancet Infectious Diseases.

[36]  Y. Xiong,et al.  Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China , 2020, JAMA network open.

[37]  L. Leinwand,et al.  Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers , 2020, medRxiv : the preprint server for health sciences.

[38]  A. Schuchat,et al.  Superspreading SARS Events, Beijing, 2003 , 2004, Emerging infectious diseases.

[39]  Sheng Zhang,et al.  Profile of RT-PCR for SARS-CoV-2: A Preliminary Study From 56 COVID-19 Patients , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  Dena Goffman,et al.  Universal Screening for SARS-CoV-2 in Women Admitted for Delivery , 2020, The New England journal of medicine.

[41]  Henrik Stryhn,et al.  Selection of a Cutoff Value for Real-Time Polymerase Chain Reaction Results to Fit a Diagnostic Purpose: Analytical and Epidemiologic Approaches , 2011, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[42]  M. Kulldorff,et al.  Geographic Clusters in Underimmunization and Vaccine , 2015 .

[43]  G. Ebel,et al.  Longitudinal Surveillance for SARS-CoV-2 RNA Among Asymptomatic Staff in Five Colorado Skilled Nursing Facilities: Epidemiologic, Virologic and Sequence Analysis , 2020 .

[44]  B. Singer,et al.  The implications of silent transmission for the control of COVID-19 outbreaks , 2020, Proceedings of the National Academy of Sciences.

[45]  M. Cevik,et al.  SARS-CoV-2, SARS-CoV-1 and MERS-CoV Viral Load Dynamics, Duration of Viral Shedding and Infectiousness: A Living Systematic Review and Meta-Analysis , 2020, SSRN Electronic Journal.

[46]  Yicheng Fang,et al.  Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR , 2020, Radiology.

[47]  Nicholas P. Tatonetti,et al.  Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions , 2020, bioRxiv.

[48]  P. Sorger,et al.  SARS-CoV-2 infection protects against rechallenge in rhesus macaques , 2020, Science.

[49]  Eriko,et al.  Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR assays , 2020 .

[50]  Martin Kulldorff,et al.  Geographic Clusters in Underimmunization and Vaccine Refusal , 2015, Pediatrics.

[51]  J. Ruijter,et al.  Amplification of nonspecific products in quantitative polymerase chain reactions (qPCR) , 2017, Biomolecular detection and quantification.

[52]  S. Sawyer,et al.  A community-deployable SARS-CoV-2 screening test using raw saliva with 45 minutes sample-to-results turnaround , 2020, medRxiv.

[53]  Malik Peiris,et al.  Viral dynamics in mild and severe cases of COVID-19 , 2020, The Lancet Infectious Diseases.

[54]  Jean Thierry-Mieg,et al.  Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions , 2020, bioRxiv.

[55]  G. Ebel,et al.  Longitudinal Surveillance for SARS-CoV-2 Among Staff in Six Colorado Long-Term Care Facilities: Epidemiologic, Virologic and Sequence Analysis , 2020, medRxiv.

[56]  H. Tani,et al.  Viral load dynamics in transmissible symptomatic patients with COVID-19 , 2020, medRxiv.

[57]  S. Ruggles Integrated Public Use Microdata Series , 2021, Encyclopedia of Gerontology and Population Aging.

[58]  Hannah Fry,et al.  Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study , 2020, The Lancet Infectious Diseases.

[59]  Yiu Chung Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[60]  S. Alexandersen,et al.  SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication , 2020, Nature Communications.

[61]  Haiyan Wang,et al.  Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers , 2020, Frontiers in Medicine.